E
Zentalis Pharmaceuticals, Inc. ZNTL
$1.77 -$0.04-2.21%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -179.28M -194.65M -218.90M -292.19M -286.25M
Total Depreciation and Amortization 1.31M 1.34M 1.35M 1.39M 1.41M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 5.41M 14.10M 13.46M 77.12M 80.70M
Change in Net Operating Assets 804.00K 12.84M -6.42M 5.86M -421.00K
Cash from Operations -171.76M -166.38M -210.51M -207.82M -204.55M
Capital Expenditure -394.00K -485.00K -623.00K -583.00K -570.00K
Sale of Property, Plant, and Equipment 65.00K 65.00K -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 102.55M -63.06M -24.41M -43.88M -13.72M
Cash from Investing 102.22M -63.48M -25.03M -44.46M -14.29M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 349.00K 566.00K 237.18M 237.30M 287.04M
Repurchase of Common Stock -241.00K -241.00K -241.00K -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 108.00K 325.00K 236.94M 237.30M 287.04M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -69.43M -229.53M 1.39M -14.98M 68.20M
Weiss Ratings